Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose.

405 FDA drug recalls with this cause, newest first.

These recalls happen when a tablet or capsule does not dissolve the way its specification requires. Because dissolution controls how the drug is released, a failure can mean a patient absorbs it too slowly, too quickly, or not at all - a particular concern for extended-release products, where the release profile is the whole point.

Class II · Moderate risk

Prasugrel Tablets

Failed Dissolution Specifications

Ongoing Dissolution failure Golden State Medical Supply Inc. NDC 51407-444-30 D-0287-2025
Class III · Low risk

Tolterodine Tartrate Extended-Release Capsules

Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Terminated Dissolution failure The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-6592-04 D-0304-2025
Class II · Moderate risk

Prasugrel Tablets

Failed Dissolution Specifications - low dissolution results

Ongoing Dissolution failure Mylan Pharmaceuticals INC NDC 0378-5185-93 D-0280-2025
Class II · Moderate risk

Colchicine Capsules 0.6 mg

Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.

Terminated Dissolution failure Granules Pharmaceuticals Inc. NDC 70010-001-03 D-0187-2025
Class II · Moderate risk

glipiZIDE

Failed Dissolution Specifications:

Terminated Dissolution failure Amerisource Health Services LLC D-0202-2025
Class II · Moderate risk

Venlafaxine Hydrochloride

Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.

Terminated Dissolution failure The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7075-61 D-0584-2024
Class II · Moderate risk

Methylphenidate Hydrochloride

Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.

Terminated Dissolution failure Trigen Laboratories NDC 13811-708-10 D-0579-2024